The last 12 actions on file set price targets from $28.00 to $40.00, averaging $33.82.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 30 Sep 2026 | H.C. Wainwright | BUY | $35.00 |
| 29 Sep 2026 | H.C. Wainwright | BUY | $35.00 |
| 24 Sep 2026 | H.C. Wainwright | BUY | $35.00 |
| 23 Sep 2026 | J.P. Morgan | BUY | $30.00 |
| 21 Sep 2026 | Leerink Partners | BUY | $40.00 |
| 18 Sep 2026 | Guggenheim | BUY | $40.00 |
| 18 Sep 2026 | J.P. Morgan | BUY | – |
| 15 Sep 2026 | LifeSci Capital | BUY | $32.00 |
| 1 Sep 2026 | LifeSci Capital | BUY | $32.00 |
| 1 Sep 2026 | Guggenheim | BUY | $30.00 |
| 1 Sep 2026 | H.C. Wainwright | BUY | $35.00 |
| 1 Sep 2026 | J.P. Morgan | BUY | $28.00 |
No comments yet — be the first to weigh in on BLSM.